A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

Clinical trial NCT04643457 · COMPLETED

Trial details

NCT number: NCT04643457
Sponsor: UCB Biopharma SRL
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2020-11-27
Primary completion: 2024-04-23
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.